DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
PHIO Phio Pharmaceuticals
- 1.8100
- +0.0200+1.12%
Close Feb 14 16:00 ET
- 1.8400
- +0.0300+1.66%
Pre 07:08 ET
8.65MMarket Cap-0.19P/E (TTM)
1.8800High1.7900Low257.85KVolume1.8300Open1.7900Pre Close468.46KTurnover5.40%Turnover RatioLossP/E (Static)4.78MShares10.350052wk High1.75P/B8.64MFloat Cap1.530052wk Low--Dividend TTM4.77MShs Float3118.4994Historical High--Div YieldTTM5.03%Amplitude1.5300Historical Low1.8160Avg Price1Lot Size
About Phio Pharmaceuticals Company
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
Company Profile
SymbolPHIO
Company NamePhio Pharmaceuticals
Listing DateFeb 11, 2014
Founded2011
CEOMr. Robert J. Bitterman
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address11 Apex Drive,Suite 300A PMB 2006
CityMarlborough
ProvinceMassachusetts
CountryUnited States of America
Zip Code01752
Phone1-508-767-3861
Websitehttp://www.phiopharma.com
Company Executives
- Name
- Position
- Salary
- Robert J. Bitterman
- Chairman of the Board, Chief Executive Officer and President
- 437.89K
- Robert M. Infarinato
- Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Caitlin Kontulis
- Principal Accounting Officer, Vice President, Finance and Administration and Secretary
- --
- Patricia A. Bradford
- Independent Director
- 57.86K
- Dr. Curtis A. Lockshin, PhD
- Independent Director
- 50.36K
- Dr. Jonathan E. Freeman, PhD
- Independent Director
- 42.86K
- Robert L. Ferrara
- Lead Independent Director
- 70.36K